Schizophrenia.com

Intra-Cellular Therapies Announces Completion of Phase 1 Studies for ITI-214, a Phosphodiesterase Type 1 Inhibitor, and Assumes IND Sponsorship for ITI-214

http://globenewswire.com/news-release/2015/09/21/769848/10150056/en/Intra-Cellular-Therapies-Announces-Completion-of-Phase-1-Studies-for-ITI-214-a-Phosphodiesterase-Type-1-Inhibitor-and-Assumes-IND-Sponsorship-for-ITI-214.html

http://seekingalpha.com/news/2790436-takeda-backs-out-of-itiminus-214-development-intra-cellular-assessing-options-in-several-indications

3 Likes